Our Team

Ein Bild, das Menschliches Gesicht, Person, Lächeln, Porträt enthält. KI-generierte Inhalte können fehlerhaft sein.

PD Dr. Heiko Funke-Kaiser, MD

Medical specialization and habilitation in pharmacology and toxicology. Within his work, he focuses on molecular mechanisms of oncological and cardiovascular diseases as well as on drug discovery/ development.

Ein Bild, das Menschliches Gesicht, Porträt, Person, Kleidung enthält. KI-generierte Inhalte können fehlerhaft sein.

Prof. Thomas Unger, MD, PhD

Former Scientific Director of CARIM - School for Cardiovascular Diseases (Maastricht University). Former Head of the Center for Cardiovascular Research (CCR) and the Institute of Pharmacology at Charité. As key opinion leader Thomas Unger is known for his work on the renin-angiotensin system (RAS).

Ein Bild, das Menschliches Gesicht, Person, Mann, Vorderkopf enthält. KI-generierte Inhalte können fehlerhaft sein.

Dmitry Kuznetsov, M.A.

Dmitry joined CCRP Therapeutics as a consultant in 2020 and became CEO in 2023. He holds an MA in Economics and Management from Humboldt University of Berlin, along with certifications in Energy Risk (GARP) and Clinical Trials (Dr. Notghi Academy). With extensive global financial market experience, he drives CCRPt’s strategic growth, financial planning, investor relations, and fundraising.

Ein Bild, das Menschliches Gesicht, Person, Porträt, Kleidung enthält. KI-generierte Inhalte können fehlerhaft sein.

Prof. Werner Skuballa, PhD

Former Head of Medicinal Chemistry 5 Schering AG. Werner Skuballa worked on the chemistry of prostaglandins, prostacyclins. lipoxins, thromboxanes, leukotrienes, steroids, macrolactones, kinase-inhibitors, interleukins and natural compounds.